Often, the treatment options for this type of back pain are also more limited, making an already troublesome issue even worse
3 Frontiers in Pharmacology (2024)NNMT as a candidate therapeutic target for metabolic syndrome (review)
Research reviews describe BPC-157 as a synthetic peptide derived from gastric proteins that appears to influence angiogenesis, collagen synthesis, fibroblast activity, nitric oxide pathways, and growth factor signaling
Clinical trials involving over 900 human subjects across six randomized, double-blind, placebo-controlled studies confirmed the safety profile
If the six peptides are added to the 503A list, a licensed compounding pharmacy could prepare them for an identified patient who has a valid prescription and a genuine medical need
Child-Pugh B (moderate impairment): Start at 200 mcg subcutaneously once daily